What does stable disease mean on my Multiple Myeloma scan results

Understanding "Stable Disease" in Your Multiple Myeloma Results

Great question—understanding what your scan results mean is an important part of managing your care. Let me explain what "stable disease" means and why it matters.

What Stable Disease Means

Stable disease means your myeloma is not getting worse, but it's also not improving. In other words:

• Your cancer burden (the amount of myeloma in your body) has stayed roughly the same since your last scan
• The myeloma cells haven't increased significantly
• But they also haven't decreased significantly

Think of it like this: if your previous scan showed myeloma in certain bones, your new scan shows myeloma in about the same locations and at about the same levels.

How Doctors Measure This

According to the NCCN Guidelines for Multiple Myeloma, doctors use specific criteria to assess your response to treatment. They look at several measurements:

• M protein levels in your blood and urine (the abnormal antibodies myeloma cells produce)
• Free light chain levels (proteins released by myeloma cells)
• Imaging findings from your PET/CT, CT, or MRI scans
• Bone marrow plasma cell percentage (how many myeloma cells are in your bone marrow)

Stable disease means these measurements haven't changed by more than a certain amount—they're essentially holding steady.

Is Stable Disease Good or Bad?

This depends on your situation:

Stable disease can be positive because:

• Your current treatment is controlling the cancer
• The myeloma isn't progressing (getting worse)
• You may have time to continue your current treatment plan
• It gives your body a chance to recover from treatment side effects

However, stable disease is different from:

• Partial response – where myeloma markers decrease by at least 50%
• Very good partial response (VGPR) – where markers decrease by at least 90%
• Complete response – where myeloma markers become undetectable

What Happens Next?

If your disease is stable, your care team will typically:

1. Continue your current treatment if it's working to hold the cancer steady
2. Monitor you closely with regular blood tests and imaging (usually every 3 months, according to NCCN Guidelines)
3. Watch for any changes that might indicate progression or improvement
4. Discuss your goals with you about whether to continue, adjust, or change treatment

Important Questions to Ask Your Doctor

Since stable disease can mean different things depending on your specific situation, here are key questions:

1. "Is stable disease a good result for my particular myeloma?" (Some people achieve stable disease quickly, while others take longer—context matters)

2. "How long do you expect my disease to remain stable on this treatment?"

3. "What would cause you to change my treatment plan?" (For example, if your disease starts progressing)

4. "Are there any signs that suggest my disease might progress soon?" (Your doctor may see subtle changes that aren't yet "progression")

5. "Should I consider a different treatment, or is continuing my current plan the best option?"

6. "How often will we monitor my disease, and what tests will we use?"

The Bigger Picture

According to the NCCN Guidelines, multiple myeloma is typically a chronic condition that requires ongoing monitoring and treatment adjustments over time. Stable disease is often a realistic and meaningful goal—it means your treatment is doing its job of controlling the cancer.

However, myeloma usually progresses eventually, which is why regular follow-up is so important. Catching any changes early allows your care team to adjust your treatment before the disease becomes more difficult to control.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.